Theravance Biopharma (TBPH): Cutting PT But Only On Increased Sharecount - Leerink

October 31, 2016 7:37 AM EDT
Get Alerts TBPH Hot Sheet
Price: $31.98 +1.04%

Rating Summary:
    5 Buy, 0 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 22 | New: 54
Trade TBPH Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Leerink Partners analyst, Geoffrey Porges, reiterated his Outperform rating on shares of Theravance Biopharma (NASDAQ: TBPH) but cut the price target to $33.00 from $35.00) after last week's financing event.

The analyst stated that the new target price reflects the higher expected share count after the company's new equity issuance; not an altered outlook for the company, or its prospects.

For an analyst ratings summary and ratings history on Theravance Biopharma click here. For more ratings news on Theravance Biopharma click here.

Shares of Theravance Biopharma closed at $25.42 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change

Add Your Comment